NANOG and sarcoma: Mechanistically, we found that Ebf1-KRAB-expressing sarcoma cells exhibit a reduced enrichment of EWS/ATF1 at the super-enhancer when compared with the control NANOG-KRAB-expressing sarcoma cells (Fig. 7f).